ArticleToxins2026
Presence, Quantification, and Health Risk Assessment of Mycotoxins in Polyfloral Bee-Collected Pollen from Serbia.
Article in Toxins, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Bee-collected pollen (BCP), due to its valuable nutrient content, is considered a natural food suitable for human consumption. On the other hand, it should be noted that the rich nutritional value of BCP is also relevant in the context of potential contamination with fungal secondary metabolites, such as mycotoxins. In this study, a total of 26 pollen samples were collected from different locations in order to investigate the potential presence of mycotoxins. All BCP samples were obtained from beekeepers who produce pollen for further commercialization. The analyzed mycotoxins included ochratoxin A (OTA), aflatoxin B1 (AFB1), zearalenone (ZEN), T-2 toxin, HT-2 toxin, deoxynivalenol (DON), and fumonisins (FUMs), which were measured by direct competitive enzyme-linked immunosorbent assays. The obtained results indicated the presence of at least three toxins in all samples. AFB1, OTA, and ZEN were detected above the limit of quantification (LOQ) in all samples, whereas T-2 and HT-2 were below the LOQ in five samples and DON in four samples. FUMs were below LOQ in all samples. Due to the significant content of AFB1 determined in all samples, there is a potential risk for future consumers, demanding constant monitoring as well as improvement of BCP production.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.